Searched for
CEO OF PROPRIETARY DRUGS
Mankind Pharma partners Denovo Sciences for AI-led drug discoveryMankind Pharma has partnered with Denovo Sciences to accelerate drug discovery using artificial intelligence. This collaboration aims to si...- Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discoveryMankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partner...
- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- DeepMind CEO Demis Hassabis’ Isomorphic Labs raises $2.1 billion led by Thrive CapitalAI-driven drug discovery firm Isomorphic Labs secured a massive $2.1 billion in Series B funding. This capital will fuel the expansion of t...
- Mark Zuckerberg backed-Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapyLast October, Novo Nordisk had shut down its cell therapy unit as part of a broader restructuring, discontinuing development of the therap...
- Jubilant Pharmova names Daniel J O'Connor as CEO of proprietary drugs bizJubilant Pharmova has appointed Daniel J O'Connor as the CEO of its novel drugs business. O'Connor brings over 30 years of leadership exper...
- Sun Pharma, US-based Rockwell Medical enter into licensing pact for Triferic in IndiaAs per the terms of the agreement, Sun Pharma will be the exclusive development and commercialisation partner for Triferic during the term ...
- Dr Reddy's gets FDA nod for 'Tosymra' migraine nasal sprayThe drug maker said the audit of its API manufacturing plant at Miryalaguda in Telangana, by the US FDA, has been completed.
- Dr Reddy’s top hand Alok Sonig quitsSonig handled challenging roles during his six-year tenure at the company founded and named after scientist-entrepreneur late K Anji Reddy.
- Sun Pharma gets USFDA nod for cancer treatment injectionThe approval from the USFDA is for INFUGEM injection (gemcitabine in 0.9 per cent sodium chloride injection) 10 mg/mL, for intravenous use ...
- Jubilant Life signs $180 mn outlicensing deal with Checkpoint"The pact includes an upfront payment of $2 mn and contingent pre-clinical, clinical and regulatory payments including commercials up to $1...
- Dr Reddy's Laboratories gets tentative approval from USFDA for ZenavodPromius Pharma LLC, the company's US arm will be responsible for commercialising Zenavod in the US market, it added.
- Cipla inks pact with US firm for Ropivacaine infusion systemDrug major Cipla has inked a pact with US-based BioQ Pharma for registration and commercialisation of latter's Ropivacaine infusion system.
- Dr Reddy's Laboratories may file new drug applications with FDA within yearChief Operating Officer and Member of the Management Council, DRL, Abhijit Mukherjee said one drug is currently in the late phase-III .
- Zydus joins hands with Pieris for drug developmentZydus Cadila today said it has entered into a drug development and commercialisation alliance with Germany's Pieris AG for a new therapeuti...
- Six new drugs in clinical development stage: Dr Reddy'sThe drug maker said as of March 31, 2013, DRL had 21 active products in the proprietary products pipeline, of which six are in clinical dev...
- GVK Bio, USFDA in drug repositioning collaborationThe company is looking forward to continue working with the FDA with a view to further enhancing the utility of the product, the company sa...
- Now, Indian pharma companies like Jubilant Group, TCG Life Sciences and Piramal Life Sciences venture to share new drug R&D risksIndian firms need handholding, but there have been times when they were left on their own after being assigned a project.
- NovaLead to take PE route for expansionPune-based drug discovery startup NovaLead Pharma has begun talks with an overseas consortium of private equity funds as part of a plan to ...
- Glenmark gets DGCI nod for drug trialGlenmark Pharmaceuticals Ltd today said it has received approval from the Drug Controller General of India (DCGI) to initiate phase II tria...
Load More
